4 Results for "

Avotaciclib

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Avotaciclib" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-137432
CAS No.: 1983983-41-0
Purity:  99.72%
Synonyms: BEY1107
Target:  

CDK Apoptosis

Research Areas:  

Cancer

Avotaciclib (BEY1107) is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. Avotaciclib can inhibit the proliferation and induce apoptosis of tumor cells. Avotaciclib can be used in the research of cancer such as pancreatic cancer and lung cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-137432A
CAS No.: 1983984-01-5
Purity:  99.60%
Synonyms: BEY1107 trihydrochloride
Target:  

CDK Apoptosis

Research Areas:  

Cancer

Avotaciclib (BEY1107) trihydrochloride is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. Avotaciclib trihydrochloride can inhibit the proliferation and induce apoptosis of tumor cells. Avotaciclib trihydrochloride can be used in the research of cancer such as pancreatic cancer and lung cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-137432B
Purity:  99.75%
Synonyms: BEY1107 hydrochloride
Target:  

CDK Apoptosis

Research Areas:  

Cancer

Avotaciclib (BEY1107) hydrochloride is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. Avotaciclib hydrochloride can inhibit the proliferation and induce apoptosis of tumor cells. Avotaciclib hydrochloride can be used in the research of cancer such as pancreatic cancer and lung cancer .
loading...
    loading...
Cat. No.: HY-137432D
CAS No.: 1983984-04-8
Synonyms: BEY1107 sulfate
Target:  

CDK Apoptosis

Research Areas:  

Cancer

Avotaciclib (BEY1107) sulfate is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. Avotaciclib sulfate can inhibit the proliferation and induce apoptosis of tumor cells. Avotaciclib sulfate can be used in the research of cancer such as pancreatic cancer and lung cancer .
loading...
    loading...